SEK 190 million for research and development of a new diagnostic test for Alzheimer’s disease
Alzheimer’s researcher Sebastian Palmqvist has been awarded USD 19.4 million (SEK 190 million) from the US National Institutes of Health (NIH), through its National Institute on Aging (NIA). The funds are to be used to develop a clinical test based on the biomarker MTBR-tau243. The goal is to develop an FDA-approved blood test within five years that will benefit patients. “It’s a great pleasure to
https://www.medicine.lu.se/article/sek-190-million-research-and-development-new-diagnostic-test-alzheimers-disease - 2026-09-29
